Editors/Authors
Librarians
Newsletter
Site Tour
Subscriptions
A-Z Index
About
Contact Us
Help
Log In
|
Log In via Athens
select
All JAMAevidence
Users' Guides (UG)
Rational Clinical Exam (RCE)
Care at the Close of Life (CCL)
UG Education Guides
RCE Education Guides
CCL Education Guides
Glossary
Images
Disable Autosuggest
<
Back
alteplase
Users' Guides to the Medical Literature
1-3 of 3
results
1.
Part B Therapy >
Chapter 11.2. Example Numbers Needed to Treat
> The Number Needed to Treat in Weighing Benefit and Harm >
Consider, for instance, the Global Utilization of Streptokinase and Tissue Plasminogen Activator...
2.
Part G Moving from Evidence to Action >
Chapter 22.2. Decision Making and the Patient
> Using the Guide > Box 22.2-1 > Do Decision Analyses Predict Patient Preferences? >
Heyland et al
5
asked 120 at-risk patients to consider whether they would prefer...
3.
Part B Therapy >
Chapter 6. Therapy (Randomized Trials)
> How Can I Apply the Results to Patient Care? > Are the Likely Treatment Benefits Worth the Potential Harm and Costs? >
Table 6-5 Considerations in the Decision to Treat 2 Patients With Myocardial Infarction With Tissue Plasminogen Activator or Streptokinase
RELATED SEARCH
JAMA
JAMA
and
Archives
journals
PubMed
Google Scholar
Not finding what you are looking for?
Do a full-text search for '
alteplase
'.
Copyright © American Medical Association. All rights reserved. | JAMA | McGraw-Hill Global Education Holdings, LLC.
Privacy Notice
. Any use is subject to the
Terms of Use
and
Notice
.
Additional Credits and Copyright Information
.
Your IP address is 23.22.212.158